Evaluation of Chitosan as a Natural Disintegrant in the Formulation of Aspirin Orally Disintegrating Tablets
Main Article Content
Abstract
Aspirin is an antiplatelet that is used for the therapy and prevention of stroke, many strokes occur in elderly people. Orally Disintegrating Tablet (ODT) can be dissolved quickly making it easier for geriatric patients to swallow. This study aims to determine the effect of variation in the concentration of chitosan as a disintegrating agent on the physical properties of ODT aspirin. Aspirin ODT tablets were produced by direct compression in 3 formulas with variations of chitosan of 3.5%, 7% and 14%. The results showed that a chitosan concentration of 3.5% yielded optimal tablet properties: disintegration time of 23.66 seconds, friability of 0.41%, and dissolution of 96.81%. Statistically significant differences (p < 0.05) were observed among the formulations in terms of in hardness (p = 0.027), friability (p = 0.010) and disintegration time (p = 0.000). The disintegration mechanism of chitosan involves swelling, wicking, and strain recovery. At lower concentrations, chitosan promotes rapid water uptake and particle expansion, facilitating fast breakdown of the tablet matrix. In contrast, higher chitosan levels may induce gel formation that hinders water penetration, thus delaying disintegration. In conclusion, chitosan at a concentration of 3.5% effectively functions as a natural disintegrant in aspirin ODTs, offering rapid disintegration and high dissolution, which is suitable for geriatric patients with swallowing difficulties.
Article Details
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
The authors retain the copyright and grant the journal the right of first publication simultaneously under the Creative Commons Attribution License. This license allows others to share the work with proper acknowledgment of authorship and initial publication in this journal. Authors are permitted and encouraged to deposit their articles in institutional repositories, on their personal websites, or in other online repositories after the article has been published in JSFK.
References
[1]. Food, Administration D, others. Concomitant use of ibuprofen and aspirin: potential for attenuation of the anti-platelet effect of aspirin. Food and Drug Administration Science Paper. 2006;
[2]. Stanger L, Yamaguchi A, Holinstat M. Antiplatelet strategies: past, present, and future. Journal of Thrombosis and Haemostasis. 2023;21(12):3317–28.
[3]. Yousufuddin M, Young N. Aging and Ischemic Stroke. 2019;11(9):2542–4.
[4]. Khedr EM, Abbass MA, Soliman RK, Zaki AF, Gamea A. Post-stroke dysphagia : frequency , risk factors , and topographic representation : hospital-based study. The Egyptian Journal of Neurology, Psychiatry, and Neurosurgery. 2021;57(23).
[5]. Ghourichay MP, Kiaie SH, Nokhodchi A, Javadzadeh Y. Formulation and quality control of orally disintegrating tablets (ODTs): recent advances and perspectives. BioMed Research International. 2021;2021(1):6618934.
[6]. Draksiene G, Venclovaite B, Pudziuvelyte L, Ivanauskas L, Marksa M, Bernatoniene J. Natural polymer chitosan as super disintegrant in fast orally disintegrating meloxicam tablets: Formulation and evaluation. Pharmaceutics. 2021;13(6):879.
[7]. Olorunsola EO, Akpan GA, Adikwu MU. Evaluation of Chitosan-Microcrystalline Cellulose Blends as Direct Compression Excipients. Journal of Drug Delivery. 2017;2017:1–8. https://doi.org/10.1155/2017/8563858
[8]. Suresh P, Sreedhar I, Vaidhiswaran R, Venugopal A. A comprehensive review on process and engineering aspects of pharmaceutical wet granulation. Chemical Engineering Journal. 2017;328:785–815.
[9]. Brayfield A. Martindale: The Complete Drug References. 38th ed. London: Pharmaceutical Press; 2014.
[10]. Diener H-C, Hankey GJ. Primary and Secondary Prevention of Ischemic Stroke and Cerebral Hemorrhage. Journal of the American College of Cardiology. 2020;75(15). https://doi.org/10.1016/j.jacc.2019.12.072
[11]. Mahrous GM, Kassem MG, Ibrahim MA, Auda SH. Formulation and evaluation of orally disintegrating clopidogrel tablets. Brazilian Journal of Pharmaceutical Sciences. 2016;52(2):309–17. https://doi.org/10.1590/S1984-82502016000200009
[12]. Hannan PA, Khan JA, Khan A, Saifullah S. Oral Dispersible System : A New Approach in Drug Delivery System. Indian Journal of Pharmaceutical Sciences. 2016;78(1):2–7.
[13]. Council of Europe. European Pharmacopoeia. 10th ed. Strasbourg: Council of Europe; 2020. 3330–3337 p. https://doi.org/10.1201/9781315152110
[14]. Tawfeek HM, Faisal W, Soliman GM. Enalapril maleate orally disintegrating tablets: tableting and in vivo evaluation in hypertensive rats. Pharmaceutical Development and Technology. 2017;23(5):496–503. https://doi.org/10.1080/10837450.2017.1329318
[15]. Chinwala M. Recent Formulation Advances and Therapeutic Usefulness of Orally Disintegrating Tablets (ODTs). Pharmacy. 2020;8(4):186. https://doi.org/10.3390/pharmacy8040186
[16]. Steffens KE, Wagner KG. Immediate-Release Formulations Produced via Twin-Screw Melt Granulation: Systematic Evaluation of the Addition of Disintegrants. AAPS PharmSciTech. 2021;22(5):1–13. https://doi.org/10.1208/s12249-021-02056-0
[17]. Salim I, Khalid GM, Wada AS, Danladi S, Kurfi FS, Yola UA. Critical analysis of powder flow behaviour of directly compressible coprocessed excipients. FUDMA Journal of Sciences. 2023;7(6):343–54.
[18]. Nawangsari D, Prabandari R, Febrina D. Characterization of Pregelatinized, Pentanol and Acetylated Modified Primary Starch. Viva Medika: Jurnal Kesehatan, Kebidanan dan Keperawatan. 2024;17(1):1–8.
[19]. Rahman L, Wardina H, Natsir D. Pengaruh Fermentasi Sari Kedelai dengan Lactobacillus sp. terhadap Kadar dan Profil Kromatografi Lapis Tipis Genistein serta Formulasinya dalam Granul Efervesen. Jurnal Ilmu Kefarmasian Indonesia. 2012;10(2):126–31.
[20]. Clapham D, Belissa E, Inghelbrecht S, Pensé-Lhéritier A-M, Ruiz F, Sheehan L, et al. A guide to best practice in sensory analysis of pharmaceutical formulations. Pharmaceutics. 2023;15(9):2319.
[21]. Stiyani ND, Nawangsari D, Samodra G. Formulasi dan Evaluasi Sediaan Tablet Hisap Bunga Telang (Clitoria ternatea L.) dengan Perbandingan Manitol-Sukrosa. Jurnal Mandala Pharmacon Indonesia. 2022;8(2):252–61.
[22]. Allen L V., Ansel HC. Ansel’s Pharmaceutical Dosage Forms and Drug Delivery Systems. 10th ed. Philadelphia: Lippincott Williams & Wilkins; 2015.
[23]. Departemen Kesehatan RI. Farmakope Indonesia Edisi III. Jakarta: Kementrian Kesehatan RI; 1979.
[24]. Departemen Kesehatan RI. Farmakope Indonesia Edisi VI. Jakarta: Kementrian Kesehatan RI; 2020.
[25]. Hanan, Durgin. Pharmay Practice For Technicians. 5th ed. USA: Cengage Learning; 2015.
[26]. Hobbs D, Karagianis J, Treuer T, Raskin J. An in vitro analysis of disintegration times of different formulations of olanzapine orodispersible tablet: A preliminary report. Drugs in R and D. 2013;13(4):281–8. https://doi.org/10.1007/s40268-013-0030-8
[27]. Priyatno D. Seri CD Software Olah Data Statistik Dengan Program PSPP. Yogyakarta: Mediakom; 2013.
[28]. Aulton ME, Taylor KMG. Aulton’s Pharmaceutics The Design and Manufacture of Medicines. 5th ed. Aulton’s Pharmaceutics The Design and Manufacture of Medicines. Edinburgh: Elsevier; 2018. 933 p.
[29]. Badwan AA, Rashid I, Al Omari MMH, Darras FH. Chitin and chitosan as direct compression excipients in pharmaceutical applications. Marine Drugs. 2015;13(3):1519–47. https://doi.org/10.3390/md13031519
[30]. Jiang C, Cai S, Mao L, Wang Z. Effect of porosity on dynamic mechanical properties and impact response characteristics of high aluminum content PTFE/Al energetic materials. Materials. 2020;13(1). https://doi.org/10.3390/ma13010140
[31]. Aulton ME, Taylor K. Aulton’s Pharmaceutical Dosage Forms and Drug Delivery Systems. 5th ed. Edinburgh: Elsevier; 2018.
[32]. Olorunsola EO, Ekong UE. Influence of chitosan concentration on mechanical and release properties of metronidazole tablet. Journal of Phytomedicine and Therapeutics. 2019;18(1):268–75.
[33]. Gujarathi SC, Shah AR, Jagdale SC, Datar PA, Choudhari VP, Kuchekar BS. Spectrophotometric simultaneous determination of aspirin and Ticlopidine in combined tablet dosage form by first order derivative spectroscopy, Area Under Curve (AUC) and ratio derivative spectrophotometric methods. International Journal of Pharmaceutical Sciences Review and Research. 2010;3(1):115–9.
[34]. Kuntari K, Aprianto T, Noor RH, Baruji B. Verifikasi Metode Penentuan Asetosal Dalam Obat Sakit Kepala Dengan Metode Spektrofotometri Uv. JST (Jurnal Sains dan Teknologi). 2017;6(1):31–40. https://doi.org/10.23887/jst-undiksha.v6i1.9398
[35]. Markl D, Zeitler JA. A review of disintegration mechanisms and measurement techniques. Pharmaceutical research. 2017;34(5):890–917.
[36]. Lin K, Wang Z. Multiscale mechanics and molecular dynamics simulations of the durability of fiber-reinforced polymer composites. Communications Materials. 2023;4(1):66.
[37]. Berardi A, Bisharat L, Quodbach J, Rahim SA, Perinelli DR, Cespi M. Advancing the understanding of the tablet disintegration phenomenon–An update on recent studies. International Journal of Pharmaceutics. 2021;598:120390.